CNBC March 27, 2024
Annika Kim Constantino

Key Points

– Moderna announced positive clinical trial data on three experimental vaccines and said it will move those shots to final stage studies.

– The update brings the biotech company a step closer to having multiple products on the market, which it badly needs amid plunging demand for Covid shots worldwide.

– Moderna will chart its post-Covid future Wednesday during its fifth annual “Vaccines Day,” an investor event in Boston.

Moderna has more to offer beyond its Covid vaccine.

The biotech company Wednesday announced positive clinical trial data on three experimental vaccines against other viruses. The company is moving those shots to final stage studies, it said.

The update brings Moderna a step closer to having multiple products on...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Clinical Trials, Pharma / Biotech, Trends
Why Conflicts Of Interest May Not Be As Bad As You Think (And Besides We All Have Them!)
11 drugs now in shortage
AbbVie tries to reassure investors on Humira biosimilar threat
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
This Biotech Startup Aims To Speed Up Drug Testing On Animals

Share This Article